Clinical use of low haemoglobin density, transferrin saturation, bone marrow morphology, Perl's stain and other plasma markers in the identification of treatable anaemia presenting for cardiac surgery in a prospective cohort study

Journal of Clinical Pathology

Volumn 68, Issue 11, 2015, Pages 923-930

  Martin Cabrera, Pedro ^a   Hung, Matthew ^b   Ortmann, Erik ^b   Richards, Toby ^c   Ghosh, Marcus ^b   Bottrill, Fiona ^b   Collier, Timothy ^d   Klein, Andrew A ^b   Besser, Martin W ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYANOCOBALAMIN; FERRITIN; FOLIC ACID; HEMOGLOBIN; HEPCIDIN; IRON; LACTATE DEHYDROGENASE; TRANSFERRIN; BIOLOGICAL MARKER;

AGED; ARTICLE; BONE MARROW; COHORT ANALYSIS; CYANOCOBALAMIN DEFICIENCY; FEMALE; FOLIC ACID DEFICIENCY; HEART SURGERY; HUMAN; IRON DEFICIENCY ANEMIA; IRON RESTRICTION; IRON STORAGE; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETICULOCYTE COUNT; SURGICAL PATIENT; THYROID DISEASE; ALGORITHM; ANEMIA; BLOOD; COMPLICATION; DIFFERENTIAL DIAGNOSIS; HEART DISEASE; PATHOLOGY; STAINING;

AGED; ALGORITHMS; ANEMIA; BIOMARKERS; BONE MARROW; CARDIAC SURGICAL PROCEDURES; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEART DISEASES; HEMOGLOBINS; HUMANS; MALE; PROSPECTIVE STUDIES; STAINING AND LABELING; TRANSFERRIN;

EID: 84945232517     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2015-203024     Document Type: Article

References (42)

1. World Health Organisation. Nutritional anaemia: report of a WHO Scientific Group. Geneva. Tech Rep Ser 1968;405:40.
2. UN Children's Fund and UN University. Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers. Secondary Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers. 2001. WHO/NHD/01.3.http://www.who.int/nutrition/publications/en/ida-assessment-prevention-control.pdf
3. Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood 2014;123:615-24.
4. Riva E, Tettamanti M, Mosconi P, et al. Association of mild anemia with hospitalization and mortality in the elderly: the Health and Anemia population-based study. Haematologica 2009;94:22-8.
5. Tettamanti M, Lucca U, Gandini F, et al. Prevalence, incidence and types of mild anemia in the elderly: the "Health and Anemia" population-based study. Haematologica 2010;95:1849-56.
6. Loor G, Koch CG, Sabik JF III, etal. Implications and management of anemia in cardiac surgery: current state of knowledge. J Thorac Cardiovasc Surg 2012;144:538-46.
7. Karkouti K, Wijeysundera DN, Yau TM, et al. The influence of baseline hemoglobin concentration on tolerance of anemia in cardiac surgery. Transfusion 2008;48:666-72.
8. Hung M, Besser M, Sharples LD, et al. The prevalence and association with transfusion, intensive care unit stay and mortality of preoperative anaemia in a cohort of cardiac surgery patients. Anaesthesia 2011;66:812-18.
9. Oo TH. The pattern of consultation referrals to a hematologist at an academic medical centre: the expanding role of a consultant hematologist. Blood 2008;112 (ASH Annual Meeting Abstracts):4673.
10. Zaucha J, Adamowicz K, Zalewska M, et al. Analysis of patient referrals to the outpatient haematology clinic in Elbag. Contemp Oncol 2011;15:385-92.
11. Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 2010;116:4754-61.
12. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002;48:1066-76.
13. Thomas DW, Hinchliffe RF, Briggs C, et al. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol 2013;161:639-48.
14. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-23.
15. Hung M, Ortmann E, Besser M, et al. A prospective observational cohort study to identify the causes of anaemia and association with outcome in cardiac surgical patients. Heart 2015;101:107-12.
16. Hughes DA, Stuart-Smith SE, Bain BJ. How should stainable iron in bone marrow films be assessed? J Clin Pathol 2004;57:1038-40.
17. Rath CE, Finch CA. Sternal marrow hemosiderin; a method for the determination of available iron stores in man. J Lab Clin Med 1948;33:81-6.
18. Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst 1999;91:1616-34.
19. Swerdlow SH, Campo E, Harris NL. Myelodysplastic myeloproliferative neoplasms. In: Cancer IAfRo, ed. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th edn. Lyon: World Health Organisation, 2008:75-86.
20. Swerdlow SH, Campo E, Harris NL. Myelodysplastic syndromes. In: Cancer IAfRo, ed. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th edn. Lyon: World Health Organisation, 2008:87-105.
21. den Elzen WP, de Craen AJ, Wiegerinck ET, et al. Plasma hepcidin levels and anemia in old age. The Leiden 85-Plus Study. Haematologica 2013;98:448-54.
22. Theurl I, Aigner E, Theurl M, et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 2009;113:5277-86.
23. Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011;117:4425-33.
24. Ganz T, Nemeth E. The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders. Hematology Am Soc Hematol Educ Program 2011;2011:538-42.
25. Hoffbrand AV, Moss PAH. Hypochromic anaemias. In: Hoffbrand AV, Moss PAH, eds. Esential haematology. 6th edn. Chichester, West Sussex, UK: Wiley-Blackwell, 2011:34-49.
26. Galesloot TE, Vermeulen SH, Geurts-Moespot AJ, et al. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood 2011;117: e218-25.
27. Koulaouzidis A, Cottier R, Bhat S, et al. A ferritin level >50 microg/L is frequently consistent with iron deficiency. Eur J Intern Med 2009;20:168-70.
28. Koulaouzidis A, Said E, Cottier R, et al. Soluble transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review. J Gastrointestin Liver Dis 2009;18:345-52.
29. Barron BA, Hoyer JD, Tefferi A. A bone marrow report of absent stainable iron is not diagnostic of iron deficiency. Ann Hematol 2001;80:166-9.
30. Urrechaga E. The new mature red cell parameter, low haemoglobin density of the Beckman-Coulter LH750: clinical utility in the diagnosis of iron deficiency. Int J Lab Hematol 2010;32(1 Pt 1):e144-50.
31. National Institute for Health and Clinical Excellence (NICE). Anaemia management in people with chronic kidney disease. Guideline 114. NICE, 2011.
32. Kemna EH, Tjalsma H, Willems HL, et al. Hepcidin: from discovery to differential diagnosis. Haematologica 2008;93:90-7.
33. Killick SB, Carter C, Culligan D, et al. Guidelines for the diagnosis and management of adult myelodysplastic syndromes. Br J Haematol 2014;164:503-25.
34. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-99.
35. Devalia V, Hamilton MS, Molloy AM, et al. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol 2014;166:496-513.
36. Solomon LR. Cobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methylmalonic acid, and homocysteine testing. Blood 2005;105:978-85; author reply 1137.
37. Nightingale S, Vitek PJ, Himsworth RL. The haematology of hyperthyroidism. Q J Med 1978;47:35-47.
38. Ford HC, Carter JM. The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis. Postgrad Med J 1988;64:735-42.
39. How J, Davidson RJ, Bewsher PD. Red cell changes in hyperthyroidism. Scand J Haematol 1979;23:323-8.
40. Germing U, Strupp C, Kundgen A, et al. No increase in age-specific incidence of myelodysplastic syndromes. Haematologica 2004;89:905-10.
41. Buckstein R, Jang K, Friedlich J, et al. Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: a retrospective study of 322 bone marrows. Leuk Res 2009;33:1313-18.
42. Worlledge SM. The interpretation of a positive direct antiglobulin test. Br J Haematol 1978;39:157-62.